Refeyn
Refeyn pioneers analytical instruments that put molecular mass measurement capabilities within easy reach for scientists. Refeyn’s unique products measure the mass of individual proteins, nucleic acids, complexes and viruses directly in solution – providing vital insights for scientific discovery, research and development and therapeutics production.
Latest Content
Product News
Mass Photometry Recognized by US Pharmacopeia in New AAV Reference Standards for Gene Therapy Quality
Refeyn has announced that mass photometry has been recognized by the US Pharmacopeia (USP) as a key orthogonal method for characterizing USP’s new AAV reference standards.
Listicle
Creating Space in Science: LGBTQIA+ Voices on Belonging in Pharma
In this listicle, LGBTQIA+ scientists offer insights into how inclusion can be built into everyday lab culture, from normalizing pronoun sharing and celebrating diverse holidays to rethinking policy and representation.
Product News
Major Mass Photometry Milestone Achieved by Refeyn With 500th Installation Globally
Refeyn’s mass photometry tech reaches 500 installs, advancing protein research in disease and drug development globally.
Product News
Refeyn Launches Software Platform To Automate Mass Photometry Analysis Workflows
Refeyn, has developed and launched a custom software platform providing automated analysis of large mass photometry data sets.
Product News
Refeyn Introduces New Mass Photometry Products To Streamline Biomolecular Analysis Workflows
Upgraded MassFluidix HC system launched in response to customer feedback, optimizing efficiency and quality of mass photometry experiments.
Product News
Refeyn Establishes New Mass Photometry Scientific Advisory Board To Maximize Potential of Transformative Technology
Refeyn, announces that it has established a new Scientific Advisory Board, chaired by Justin Benesch, Professor of Biophysical Chemistry, Oxford University and co-founder of Refeyn.
Webinar
Enhancing the Development of AAV-Based Therapeutics With Mass Photometry
On-Demand
A major challenge when developing AAV-based therapeutics is ensuring that empty AAVs that lack therapeutic DNA are removed, increasing the efficacy of the product.
Product News
Refeyn Announces Appointment of Fiona Coats as Chief Marketing Officer
Refeyn, is delighted to announce the appointment of Fiona Coats as Chief Marketing Officer, effective from June, 2024.
App Note / Case Study
Advancing Monoclonal Antibody Stability Studies With Mass Photometry
Mass photometry is an innovative biophysical analysis tool used to study the native behavior of biomolecules with minimal sample preparation.
Webinar
Advancing mAb Stability Studies With Mass Photometry
On-Demand
In this webinar, you’ll discover how mass photometry can be used for forced antibody degradation assessment, a crucial aspect of research and development for recombinant mAb therapeutics.
Advertisement
